Skip to main content
. 2017 Jun 5;15(2):182–219. doi: 10.1177/1479972317709642

Table 5.

Neuromuscular electrical stimulation and magnetic stimulation training.

Author, year of publication Number of patients (n) Mean (SD) FEV1 (%predicted) Mean (SD) age (y) Study design Study intervention Study duration Outcome measures Significant difference within groups post training Significant change pre to post (% baseline) Significant difference between groups (% change)
Neuromuscular electrical stimulation (NMES)
Bourjeily-Habr et al., 200254 18 COPD: 9 NMES, 9 control (C) NMES: 36 (4), C: 41 (4) NMES: 59 (2), C: 62 (2) RCT NMES: 50 Hz for 200 ms every 1500 ms at initial 55 mA–120 mA (intensity increased 5 mA/week) for 20 minutes each limb (quadriceps, hamstrings, and calf muscles). C: no active electrical stimulation 6 weeks (3x/w) Maximal quadriceps strength: isokineticb Maximal hamstring strength: isokineticb NMES (p = 0.004) ns C NMES (p = 0.02) ns C ↑39% – ↑33.9% – NMES > C (p = 0.046) NMES > C (p = 0.038)
Neder et al., 200255 15 COPD: 9 NMES, 6 control first 6 weeks + NMES last 6 weeks (C) NMES: 38 (10); C: 40 (13) NMES: 67 (8); C: 65 (5) RCT NMES: 50 Hz, pulse width 300–400 µs, 2 seconds on–18 s off (progressed to 10 s on –30 s off) at 10–20 mA (progressed to 100 mA) for 15 minutes each leg (progressed to 30 minutes), quadriceps femoris muscle C: receive NMES after a control period 6 weeks (5x/w) Maximal quadriceps strength: isokinetic (70°/second)b Quadriceps strength: isometricb Quadriceps endurance isokinetic: 1 minute maximal number of contractions at angular velocity 70°/second (fatigue index)b C last 6 weeks (p < 0.05) Not reported NMES ns NMES ns C last 6 weeks C last 6 weeks (p < 0.05) Not reported NMES e – – – ↓e NMES > C (p < 0.05)d ns between groupsd NMES > C (p < 0.05)d
Dal Corso et al., 200756 17 COPD: assigned to NMES followed by sham or sham followed by NMES All COPD: 50 (13) All COPD: 66 (7) Cross-over RCT (due to no significant effect of treatement sequence all the subjects were seen as a single group) NMES: 50 Hz, pulse width 400 µs, 2 seconds on–10 seconds off (progressed to 10 seconds on–20 seconds off) at 10 to 25 mA (progressed weekly with 5 mA) for 15 minutes each leg (progressed to 60 minutes), quadriceps femoris muscle. Sham: 10 Hz, pulse width 50 µs at 10 mA for 15 minutes each leg (quadriceps femoris muscle) 6 weeks (5x/w) Concentric contraction of quadriceps: isokinetic (60°/second)b Right leg muscle mass (DEXA) ns ns – – – –
Napolis et al., 201157 30 COPD: assigned to NMES followed by sham or sham followed by NMES All COPD: 50 (13) All COPD: 64 (7) Cross-over RCT NMES: 50 Hz, 300–400 µs pulse width, 2 seconds on–10 seconds off (progressed to 10 seconds on–20 seconds off) at 15–20 mA (progressed to 60 mA) for 15 minutes each leg (progressed to 60 minutes), quadriceps femoris muscle; Sham: 50 Hz, 200 µs pulse width, 2 seconds on–10 seconds off at 10 mA for 15 minutes each leg (quadriceps femoris muscle) 6 weeks (5x/w) Quadriceps strength: isokineticb Quadriceps strength: isometricb ns NMES ns sham ns NMES ns sham – – – – ns between groups Not reported
Vivodtzev et al., 201258 20 COPD: 12 NMES, 8 sham NMES: 34 (3) Sham: 30 (4) NMES: 70 (1) Sham: 68 (3) RCT NMES: 50 Hz, 400 µs pulse width, 6 seconds/16 seconds on-off cycle, intensity set at patients tolerance for 35 minutes quadriceps muscle and 25 minutes calf muscle Sham: 5 Hz, 100 µs pulse width 6 weeks (5x/w) Quadriceps strength: isometrica Quadriceps endurance: maintain 60% MVC until exhaustion (time to fatigue = time when isometric contraction dropped to 50% MVC)a Midthigh muscle CSA (CT) Calf muscle CSA (CT) Not reported NMES Not reported sham Not reported NMES Not reported sham Not reported NMES Not reported sham Not reported NMES Not reported sham ↑11% Not reported ↑37% Not reported ↑6% Not reported ↑6% Not reported NMES > sham (p < 0.03) NMES > sham (p < 0.03) NMES > sham (p < 0.05) NMES > sham (p < 0.05)
Vieira et al., 201459 20 COPD: 11 NMES, 9 sham NMES: 37 (11); Sham: 40 (14) NMES: 56.3 (11); Sham: 56.4 (13) RCT NMES: 50 Hz, 300–400 µs pulse width, 2 seconds on–18 seconds off (progressed to 10 seconds on –30 seconds off) at 15–20 mA (progressed to 100 mA) for 60 minutes twice a day, bilateral quadriceps Sham: no stimulation current 8 weeks (5x/w) Thigh circumference (after 4 weeks) NMES (p < 0.01) ns sham ↑2.9% – NMES > sham (p < 0.01)d
Maddocks et al., 201660 52 COPD: 25 NMES, 27 sham NMES: 31 (11); Sham: 31 (13) NMES: 70 (11) Sham: 69 (9) RCT NMES: 50 Hz, 350 µs pulse width, 2s/15 seconds on–off (progressed to 10 s on–15 s off) at 0–120 mA (progressed based on patients tolerance) for 30 minutes, bilateral quadriceps muscle Sham: 0–20 mA 6 weeks (7x/w) Quadriceps unpotentiated twitch (adjusted for baseline) Quadriceps strength: isometrica Rectus femoris CSA (ultrasound) NMES (p < 0.05) ns sham NMES (p < 0.05) ns sham NMES (p < 0.05) ns sham ↑14% – ↑14.8% – ↑19.7% – NMES > sham (p = 0.045) NMES > sham (p = 0.028) NMES > sham (p = 0.003)
Magnetic stimulation training (MST)
Bustamante et al., 201061 18 COPD: 10 MST, 8 control (C) MST: 30 (7) C: 35 (8) MST: 61 (6) C: 62 (8) RCT MST: 15 Hz, 2 seconds on, 4 seconds off at intensity 40% (increased by 2–3% every session) for 15 minutes each thigh C: no intervention 8 weeks (3x/w) MVC quadriceps: isometrica Quadriceps endurance isometric: maximal sustainable time for leg extensions of the dominant leg bearing 10% of MVC (12 contractions per minute)a Unpotentiated twitch quadriceps MST (p = 0.005) ns C MST (p = 0.05) ns C ns MST ns C ↑17.5% – ↑44% – – – Not reported Not reported Not reported

ns: not significant; RCT: randomized controlled trial; RM: repetition maximum; FEV1: forced expired volume in 1 second; MVC: maximum voluntary contraction; CSA: cross-sectional area; CT: computed tomography; DEXA: dual energy x-ray absorptiometry.

aMeasured via strain-gauge system.

bMeasured via computerized dynamometer, for example, Biodex.

cMeasured via hand-held dynamometer.

dBetween groups difference based on post training value.

eData not reported.